Lewis Y Antigen as Detected by the Monoclonal Antibody BR96 is Expressed Strongly in Prostatic Adenocarcinoma
- 1 May 1995
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 153 (5) , 1572-1574
- https://doi.org/10.1016/s0022-5347(01)67464-0
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Tumor Associated Glycoprotein-72 is Highly Expressed in Prostatic AdenocarcinomasJournal of Urology, 1994
- In vitro and in vivo characterization of BR96 sFv-PE40. A single-chain immunotoxin fusion protein that cures human breast carcinoma xenografts in athymic mice and rats.The Journal of Immunology, 1994
- (6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicinBioconjugate Chemistry, 1993
- Cure of Xenografted Human Carcinomas by BR96-Doxorubicin ImmunoconjugatesScience, 1993
- Antitumor activity of the single-chain immunotoxin BR96 sFv-PE40 against established breast and lung tumor xenografts.The Journal of Immunology, 1993
- Radical Prostatectomy for Clinical Stage T1-2N0M0 Prostatic Adenocarcinoma: Long-Term ResultsJournal of Urology, 1990
- Prostatic Intra-Epithelial Neoplasia and Early Invasion in Prostate CancerCancer, 1987
- Intraductal dysplasia: A premalignant lesion of the prostateHuman Pathology, 1986
- Experience with Gleason’s Histopathologic Grading in Prostatic CancerJournal of Urology, 1980